Groundbreaking stem cell trial offers hope for incurable lung disease
NCT ID NCT04262167
Summary
This early-stage study is testing whether stem cells grown from a patient's own lung tissue can safely slow down or improve progressive lung scarring. 24 adults with idiopathic pulmonary fibrosis will receive either standard care or an infusion of their own lung stem cells at two different doses. Researchers will monitor safety and look for signs that the treatment might help preserve lung function over two years of follow-up.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS AND PROGRESSIVE FIBROTIC INTERSTITIAL LUNG DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of North Carolina as Chapel Hill
Chapel Hill, North Carolina, 27514, United States
Conditions
Explore the condition pages connected to this study.